Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrataGraft for deep partial-thickness thermal burns
NCT03005106Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- May 2017
- Primary completion
- Jul 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen in Thermal Burn, sponsored by Mallinckrodt Pharmaceuticals. Started May 2017; status: completed.
02
Drugs
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT03005106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005106.